Smith & Nephew (SNNUF) Total Debt Growth (1y) (2010 - 2018)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.03% |
| Dec 31, 2017 | -12.12% |
| Dec 31, 2016 | 11.49% |
| Dec 31, 2015 | 191.81% |
| Jun 30, 2015 | 35.80% |
| Dec 31, 2014 | -564.55% |
| Sep 30, 2014 | -569.90% |
| Jun 28, 2014 | -492.84% |
| Mar 31, 2014 | 61.24% |
| Dec 31, 2013 | -19.30% |
| Sep 28, 2013 | -1,706.25% |
| Jun 29, 2013 | -2,333.33% |
| Mar 31, 2013 | 1,293.33% |
| Dec 31, 2012 | 2,587.50% |
| Dec 31, 2011 | -97.51% |
| Dec 31, 2010 | 158.90% |